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lopathy (HIE) is a leading cause of dis-
ability in full-term newborns. Long-term 
consequences of HIE, even when treated 
by hypothermia, are not easily predictable. 
Aims. To assess the potential role of elec-
troencephalography and neuroimaging 
parameters as early predictors of neurode-
velopmental outcome in HIE newborns 
treated with hypothermia.
Methods. We retrospectively evaluated 13 
HIE patients treated with hypothermia 
in January 2012-September 2014. We re-
viewed their amplitude-integrated electro-
encephalography (a-EEG) at 6, 12 and 24 
hours (h), cranial ultrasonography (US) at 
12, 72 h and >7 days of life (DOL) and brain 
magnetic resonance (MRI) performed at 
7-28 DOL, according to validated scores. 
aEEG, US and MRI patterns were correlat-
ed to neurodevelopmental outcome at 18-
24 months, considered as negative if one of 
the following was present: Mental Devel-
opment Index (MDI)<85, motor, visual or 
hearing impairment.  
Results.  The severity of a-EEG, US and 
MRI alterations at each time point was 
not different according to the outcome. 
MDI was negatively correlated with aEEG 
score at 12h (R= -0.571, p=0.04) and with 
US score at 72h (R= -0.630, p=0.02). A 
positive correlation was found between 
aEEG score at 6h and US score at >7DOL 
(R=0.690, p=0.013).  US alterations of the 
cortical matter at 72h were directly corre-
lated with a-EEG score at 12h (R = 0.606, 
p=0.028) and 24h (R=0.605, p=0.029). 
Conclusions. Early instrumental evalua-
tions, in particular aEEG and US, seem 
to predict neurodevelopmental outcome 
at 18-24 months in HIE newborns treated 
with hypothermia. 
Key words: asphyxia, hypoxic-ischemic en-
cephalopathy, hypothermia, newborn
INTRODUCTION
Hypoxic-ischemic encephalopathy (HIE), 
following neonatal asphyxia, is a leading 
cause of neurological disability in new-
borns: (1) it can result in serious con-
sequences such as death, cerebral palsy, 
epilepsy, cognitive, behavioural and devel-
opmental deficits. (2,3) Brain damage is an 
evolutionary process characterized by an 
acute stage of neuronal necrosis followed 
by  a phase of reperfusion injury charac-
terized by neural apoptosis. Hypothermic 
treatment limits  brain damage, reducing 
mortality and disability at 18-24 months of 
life. (4) However, long-term consequences 
of perinatal asphyxia are not easily predict-
able. (3)
Therefore, the aim of this study was to as-
sess the potential role of amplitude-inte-
grated electroencephalography (a-EEG) 
background patterns, cranial ultrasonogra-
phy (US) and cerebral magnetic resonance 
imaging (MRI) findings as early predictors 
of neurodevelopmental outcome at 18 -24 
months in neonates undergoing therapeu-
tic hypothermia for HIE.
MATERIALS AND METHODS
We retrospectively analysed data of all 
the patients who underwent hypother-
mic treatment from 1 January 2012 to 30 
September 2014 in the Neonatal Intensive 
Care Unit of Maggiore della Carità Univer-
sity Hospital, Novara, Italy. Hypothermic 
treatment was performed according to the 
current national guidelines for the man-
agement of HIE. (5,6) 
For each subject, a-EEG, cranial US and 
cerebral MRI, performed at scheduled 
time-points, were reviewed according to 
validated scores. (7-9) 
a-EEG
A trained nurse or technician applied sur-
face electrodes at C3-C4 locations accord-
ing to the international 10 –20 system. 
a-EEG was recorded for all the cooling 
period and for six hours after rewarming. 
a-EEG recordings were reviewed by a pedi-
atric neurologist (C.P.) skilled in neonatal 
a-EEG and blinded to clinical factors. A 
severity score, based on the classification 
reported by Murray et al. (7) was assigned 
to tracings recorded at 6, 12 and 24 hours 
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of life, as follows: 
 ■ Grade 0 (normal a-EEG): continuous 
pattern with physiological characteris-
tics 
 ■ Grade 1 (mildly abnormal): continuous 
pattern with slightly abnormal activ-
ity (slight asymmetry, mild depression 
voltage, poorly differentiated sleep-
wake cycle)
 ■ Grade 2 (moderately abnormal): dis-
continuous activities with interburst 
<10 seconds, not differentiated  sleep-
wake cycle, or clear asymmetry or asyn-
chrony
 ■ Grade 3 (severe abnormalities): discon-
tinuous activities with interburst of 10-
60 seconds, severe depression voltage, 
or lack of sleep-wake cycle
 ■ Grade 4 (inactive/flat EEG): basic ac-
tivities <10 microvolts or severe dis-
continuity with interburst range > 60 
seconds.
Cranial US
Cranial US was performed for all pa-
tients at three time-points: t = 0 (within 
24 hours), t = 72 (at 72 hours) and t> 7 
DOL (at 7-10 days of life). All US images 
were blindly reviewed by a single neona-
tologist (G.C.) skilled in cerebral US. For 
each patient different anatomical sites were 
evaluated: basal ganglia, periventricular 
and subcortical white matter, cortical grey 
matter, and the severity of injuries was 
classified according to the severity score 
proposed by DeVries. (8) 
The basal ganglia were classified as: nor-
mal in the absence of ultrasound abnor-
malities, slightly altered in the presence of 
focal hemorrhage or hyperechogenicity of 
the lateral thalamus, moderately altered in 
the case of hyperechogenicity of the thala-
mus and putamen, seriously altered if the 
caudate and the entire thalamus were in-
volved. The white and  cortical substance 
were classified as: normal in the absence 
of ultrasound abnormalities, slightly al-
tered in the case of focal hemorrhage of 
the periventricular white matter or wide-
spread hyperechogenicity predominant 
in the paraventricular and parasagittal 
areas, moderately altered in the absence 
of cortical profile in one or both  cerebral 
hemispheres, severely impaired in the case 
of diffuse hyperechogenicity of the white 
matter with greater involvement of the 
subcortical substance.
Brain MRI
Brain MRI was performed between 7 
and 28 days of life and different anatomi-
cal sites were evaluated: posterior limb of 
the internal capsule (PLIC), basal ganglia, 
periventricular white matter and subcorti-
cal and cortical grey matter. The severity 
of injuries was classified according to the 
severity score proposed by Cheong JL et 
al. (9) The PLIC was classified as normal/
abnormal, where the abnormality was de-
fined by the reduction or absence of the 
intensity signal on T1/T2 sequences and/
or by a reduced or increased diffusion in 
DWI sequences. The basal ganglia were 
classified as normal/moderately abnormal 
in the absence or minimum focal altera-
tions of signal in T1/T2 sequences and/or 
normal diffusion characteristics, and mod-
erately/severely altered in the case of mul-
tiple or diffuse signal alterations in T1/T2 
sequences and/or qualitative abnormalities 
of DWI sequences. The white matter was 
classified as normal/mildly abnormal in 
the absence or minimal alterations on T1/
T2 sequences and/or in the case of normal 
diffusion characteristics in DWI sequenc-
es, and as moderately/severely abnormal 
in the case of signal alterations in T1/T2 
or diffusion alterations in DWI sequences 
extending to the subcortical white matter 
or in more than three white matter areas.
The cortical gray matter was classified as 
normal/mildly abnormal in the absence 
of signal alterations in T1/T2 or diffusion 
abnormalities in 2 or less areas (including 
the central sulcus, the inter-hemispheric 
fissure and the insular region), and moder-
ately/severely abnormal in the case of more 
extensive involvement.
Neurodevelopmental evaluation
For all patients, a development evalua-
tion was performed between 18 and 24 
months of life by a pediatric neurologist 
(R.P.). Children were tested by Mental 
Development Index (MDI) of the Bayley 
Scales of Infant Development and clas-
sified according to their score as subjects 
with accelerated performance (MDI≥115), 
within the normal range (MDI 85-114), 
slightly delayed (MDI 70-84) and signifi-
cantly delayed (MDI ≤69). (10) Neurologi-
cal examination was performed according 
to Amiel Tison assessment, (11) and the 
presence of motor, hearing or visual im-
pairment at 18-24 months was recorded in 
order to set the grade of disability. Patients 
were divided into two groups according to 
their neurodevelopmental outcome at 18-
24 months, considered as negative if one 
of the following was present: Mental De-
velopment Index (MDI) score <85, motor, 
hearing or visual impairment.
Statistical analysis
Data are presented as numbers (percentag-
es) or mean values (±SD). Differences be-
tween subjects with positive and negative 
neurodevelopmental outcome were evalu-
ated by chi-square test (or Fischer test as 
appropriate) for categorical variables and 
by Mann-Whitney U test for continuous 
variables.
Correlation analyses were performed by 
Spearman's rank test.
A p value <0.05 was considered significant. 
Statistical analysis was performed using 
SPSS version 17.0 (Chicago, IL, USA). 
RESULTS
The study population consisted of 13 pa-
tients (M:F = 6:7). Out of 13 enrolled pa-
tients, 8 (61.5%) had a positive neurode-
velopmental outcome (M:F = 6:2) and 5 
(38.5%) had a negative outcome (M: F = 1: 
4) at 18-24 months. Characteristics of en-
rolled patients for the four items included 
in the definition of neurodevelopmental 
outcome (MDI score, motor, hearing and 
visual impairment) are shown in table 
1. Mean MDI score at 18-24 months was 
104.38 ± 13.75 in the group with a positive 
outcome and 88.5 ± 20.4 in the negative-
outcome group.
The a-EEG severity scores at 6, 12 and 24 
hours were not different in subjects with 
positive and negative neurodevelopmental 
outcomes. Globally, there was an improv-
ing trend from 6 to 24 hours, with an in-
crease in slight alterations at the expense of 
severe ones (table 2).
In regard to the cranial US, the two groups 
of subjects with positive and negative neu-
rodevelopmental outcomes did not differ 
in severity of alterations in any anatomical 
site and at any time (table 3).
In regard to the brain MRI, the two groups 
did not differ in severity of alterations in 
any anatomical site. Severe anomalies were 
recorded at all sites in one patient belong-
ing to the group with a negative outcome 
(table 4).
CORRELATION ANALYSIS 
MDI score was negatively correlated with 
the severity of a-EEG alterations at 12 
hours (R= -0.571, p=0.042, df=11 for two-
tailed test) and with the severity of cortical 
alterations evaluated by US at 72 hours (R= 
-0.630, p=0.021, df=11 for two-tailed test).
The severity of US anomalies of the white 
matter at 7 DOL showed a direct correla-
tion with the alterations of a-EEG recorded 
at 6 hours (R=0.690, p=0.013, df=11 for 
two-tailed test). 
The severity of US alterations of the corti-
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cal matter at t=72h was directly correlated 
with the severity of a-EEG alterations at 
12 hours (R=0.606, p =0.028, df=11 for 
two-tailed test) and at 24 hours (R=0.605, 
p=0.029, df=11 for two-tailed test). 
DISCUSSION
This  study aimed to analyse the presence 
of early anomalies detected by a-EEG, cra-
nial US and brain MRI, in neonates under-
going therapeutic hypothermia for HIE, 
and to assess their potential prognostic 
value with respect to neurodevelopmental 
outcomes at 18 -24 months.
Out of 13 newborns treated with therapeu-
tic hypothermia for HIE, five had a nega-
tive outcome at 18-24 months on the basis 
of a pathological MDI and/or the presence 
of motor, hearing and/or visual impair-
ment.
The first instrumental parameter taken 
into account was a-EEG recorded at 6, 12 
and 24 hours of birth. No difference was 
found in the a-EEG severity scores at each 
time point between subjects with positive 
and negative neurodevelopmental out-
comes. However, it could be supposed that 
it may be due to the small sample size, as 
at all times the prevalence of subjects with 
severe/flat a-EEG tended to be higher in 
subjects with a negative outcome. An im-
proving trend from 6 to 24 hours was also 
globally found, with an increase of the 
slight alterations at the expense of the se-
vere ones, that, however, tended to persist 
into the negative outcome group. Moreo-
ver, the severity of a-EEG alterations at 12 
hours was indirectly correlated to MDI at 
18-24 months, suggesting the potential 
prognostic value of a-EEG performed at 
12 hours of life. Our findings are consist-
ent with the results reported by Murray et 
al., (7) highlighting the improvement of 
EEG alterations from 6 to 48 hours and 
suggesting the importance of perform-
ing early EEG assessments as predictors 
of outcome after perinatal asphyxia, since 
normal or mildly abnormal EEG results 
within 6 hours of life were associated with 
normal neurodevelopmental outcomes at 
24 months. Also, in the systematic review 
by van Laerhoven et al., (3) a-EEG was the 
most promising test with a sensitivity of 
93% and a specificity of 90% in predicting 
long term neurodevelopmental outcomes.
Regarding imaging methods, no signifi-
cant difference was  found in the sever-
ity score of US and MRI alterations at any 
time and in any site according to  neu-
rodevelopmental outcome. However, it 
should be pointed out that only one sub-
ject showed severe alterations at all ana-
tomical sites both on US and MRI, and 
he developed severe neurological sequelae 
(cerebral palsy with spastic-dystonic quad-
riplegia, serious impaired motor functions, 
slurred speech and feeding difficulties). 
The severe alterations were not present on 
US imaging performed at 24 hours of life, 
and appeared starting from 72 hours, per-
sisting at the following time-points. From a 
long-term perspective, correlation analysis 
showed that MDI at 18-24 months was in-
versely correlated with the severity of US 
alterations of cortical matter at 72 hours, 
that was directly related with the severity 
of a-EEG alterations at 12 and 24 hours. 
Moreover, later alterations of the white 
matter, observed by cranial US at 7 DOL, 
showed a direct correlation with a-EEG 
alterations at 6 hours. Our data showed a 
tight interplay between a-EEG and cranial 
US in detecting anomalies following HIE. 




















































MDI, Mental Development Index.
Table 2. Distribution of a-EEG patterns at 6, 12 and 24 hours in all subjects divided ac-








a-EEG at 6 hours
0 (normal) 0 0 0 0.229
1 (mildly impaired) 1 (7.7%) 1 (12.5%) 0
2 (moderately impaired) 7 (53.8%) 5 (62.5%) 2 (40%)
3-4 (severe/flat) 5 (38.5%) 2 (25%) 3 (60%)
a-EEG at 12 hours
0 (normal) 0 0 0 0.124
1 (mildly impaired) 4 (30.8%) 4 (50%) 0
2 (moderately impaired) 5 (38.5%) 2 (25%) 3 (60%)
3-4 (severe/flat) 4 (30.8%) 2 (25%) 2 (40%)
a-EEG at 24 hours
0 (normal) 1 (7.7%) 1 (12.5%) 0 0.697
1 (mildly impaired) 6 (46.2%) 3 (37.5%) 3 (60%)
2 (moderately impaired) 3 (23.1%) 3 (37.5%) 0
3-4 (severe/flat) 3 (23.1%) 1 (12.5%) 2 (40%)
Comparisons between subjects with positive and negative neurodevelopmental outcomes 
were performed by Fischer test.
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Previous data reported that cranial US has 
poor predictive accuracy, being highly ex-
aminer dependent, with a high false-posi-
tive rate. (7,12) However, due to its safety 
and availability at the bedside, it can be 
suggested that, in the presence of altera-
tions on cranial US performed starting at 
72 hours,  neuroradiological imaging and 
clinical follow-up is highly recommended 
in newborns with HIE. Conversely, normal 
cranial US findings can be reassuring of a 
positive neurodevelopmental outcome. 
In our series, no correlation was found be-
tween MRI alterations and outcome indi-
cators, probably due to the fact that only 
one subject displayed severe alterations 
on MRI. Our data are in contrast with 
those reported by van Laerhoven et al. (3) 
in their review, showing that brain MRI 
performed within two weeks of birth had 
the best sensitivity in predicting long term 
outcome. 
The main limitation of our study was the 
small sample size, but all newborns who 
underwent hypothermic treatment in the 
considered period were included in the 
analysis.
In conclusion, our data confirm that a-
EEG is the earliest method capable of 
identifying alterations with a prognostic 
neurodevelopmental value in newborns 
undergoing therapeutic hypothermia for 
HIE. Moreover, cranial US performed 
starting from 72 hours, even with the limi-
tation of low accuracy, should be consid-
ered a useful imaging technique for iden-
tifying which subjects will be deserving of 
neurological follow-up.
Table 3. Distribution of US patterns at 0, 72 hours and >7 days of life in all subjects, 













































































































































































DOL, days of life; US, ultrasound.
Comparisons between subjects with positive and negative neurodevelopmental outcomes 
were performed by Fischer test.
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Table 4. Distribution of MRI patterns in all subjects, divided according to positive or nega-
















































































MRI, magnetic resonance imaging; PLIC, posterior limb of the internal capsule.
Comparisons between subjects with positive and negative neurodevelopmental outcomes 
were performed by Fischer test.
